Has Huajian Medical, with Hong Kong stock code 01931, also started to invest in Ethereum?

On August 8, it suddenly issued three announcements, directly stating that it plans to implement a "global enhanced Ethereum treasury with downside protection" strategy, indicating a shift towards becoming a Web3 financial hub!

What's going on specifically? It has adopted a dual-track model. On one side, it is building an Ethereum reserve treasury, intending to use its own funds to make regular investments in Ethereum, which has been approved by the board, with a maximum budget of 880 million Hong Kong dollars for market purchases. On the other side, it has created an Ethereum creation engine, leveraging its Web3 exchange ivd.xyz to tokenize the intellectual property of innovative medical drugs (known as RWA), automatically converting the profits from trades into Ethereum, which will then be funneled back into the treasury, forming a closed loop.

Moreover, it has partnered with HashKey Group, a top compliance digital asset group in Asia, which can assist in executing large transactions of Ethereum, optimizing costs, and collaborating on research regarding the integration of crypto asset reserves and medical intellectual property RWA. With a compliance license backing it, this operation is much more secure.

The key point is that it has established a seven-layer downside protection mechanism, including ATM mechanisms and RWA price buyback commitments, which can mitigate the impact of Ethereum price fluctuations and safeguard shareholders' interests.

Acting quickly, on the day of the announcement, it purchased 5,190 Ethereum at an average price of 28,798.21 Hong Kong dollars, spending 149 million Hong Kong dollars, and by the end of the day, it had an unrealized profit of about 14.1764 million Hong Kong dollars. That's some impressive action!

As everyone knows, companies with substantial Ethereum reserves tend to see their stock prices surge when Ethereum rises. Standard Chartered even predicts that the price of Ethereum could exceed 4,000 USD. If Huajian Medical can smoothly advance this strategy, it might truly achieve its target of a 100 billion Hong Kong dollar market value. $ETH #ETH走势分析